Peer review reports
From: Oritavancin as sequential therapy for Gram-positive bloodstream infections
Original Submission | ||
---|---|---|
23 Jun 2023 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
16 Aug 2023 | Reviewed | Reviewer Report |
28 Aug 2023 | Reviewed | Reviewer Report |
30 Aug 2023 | Author responded | Author comments - Matthew A. Miller |
Resubmission - Version 3 | ||
30 Aug 2023 | Submitted | Manuscript version 3 |
22 Sep 2023 | Reviewed | Reviewer Report |
10 Oct 2023 | Author responded | Author comments - Matthew A. Miller |
Resubmission - Version 4 | ||
10 Oct 2023 | Submitted | Manuscript version 4 |
17 Oct 2023 | Reviewed | Reviewer Report |
Resubmission - Version 5 | ||
Submitted | Manuscript version 5 | |
Publishing | ||
18 Oct 2023 | Editorially accepted | |
24 Jan 2024 | Article published | 10.1186/s12879-023-08725-8 |